Bal Pharma Ltd.

BSE: 524824 | NSE: BALPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE083D01012 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Bal Pharma Ltd Bal Pharma Ltd. | BSE 69.17 1.46 (2.16%) | NSE 69.59 1.05 (1.53%) | Trade | Add

BSE Live

Jan 28, 16:01

69.17 1.46 (2.16%)

Volume

AVERAGE VOLUME

5-Day

4,731

10-Day

4,806

30-Day

2,557

622

Prev. Close

67.71
Open Price

67.71

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 28, 15:40

69.59 1.05 (1.53%)

Volume

AVERAGE VOLUME

5-Day

10,707

10-Day

11,854

30-Day

7,809

3,044

Prev. Close

68.54
Open Price

68.40

Bid Price (Qty.)
69.59 (20)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Bal Pharma (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	10.48	10.48	10.45	10.45	10.45
Total Share Capital	10.48	10.48	10.45	10.45	10.45
Reserves and Surplus	25.55	26.93	24.76	22.96	21.86
Total Reserves and Surplus	25.55	26.93	24.76	22.96	21.86
Total Shareholders Funds	36.03	37.41	35.20	33.40	32.30
NON-CURRENT LIABILITIES
Long Term Borrowings	21.22	22.23	25.13	14.36	9.79
Deferred Tax Liabilities [Net]	6.79	6.03	5.01	4.68	4.11
Other Long Term Liabilities	0.00	0.00	0.00	0.00	0.00
Long Term Provisions	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	28.01	28.26	30.14	19.04	13.91
CURRENT LIABILITIES
Short Term Borrowings	33.20	24.94	20.02	21.04	26.21
Trade Payables	17.17	16.42	12.67	5.13	8.87
Other Current Liabilities	9.83	12.60	7.96	9.93	5.01
Short Term Provisions	0.80	2.34	3.05	1.99	1.80
Total Current Liabilities	61.00	56.29	43.69	38.09	41.90
Total Capital And Liabilities	125.04	121.96	109.04	90.53	88.10
ASSETS
NON-CURRENT ASSETS
Tangible Assets	49.38	54.51	26.25	26.06	20.09
Intangible Assets	5.23	0.00	0.00	0.00	0.00
Capital Work-In-Progress	0.00	0.40	19.25	5.17	2.14
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	54.62	54.91	45.50	31.24	22.22
Non-Current Investments	0.06	0.09	0.09	0.15	2.41
Deferred Tax Assets [Net]	0.61	0.31	0.08	0.06	0.15
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	4.91	4.60	4.28	4.35
Total Non-Current Assets	55.28	60.22	50.26	35.72	29.14
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	28.62	23.89	25.45	23.89	24.90
Trade Receivables	31.92	29.29	23.34	21.73	22.21
Cash And Cash Equivalents	1.61	1.32	2.90	0.86	5.28
Short Term Loans And Advances	7.60	7.25	7.08	8.34	6.58
OtherCurrentAssets	0.00	0.00	0.00	0.00	0.00
Total Current Assets	69.76	61.74	58.77	54.81	58.96
Total Assets	125.04	121.96	109.04	90.53	88.10
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	0.14	2.51	9.58	6.55
CIF VALUE OF IMPORTS
Raw Materials	22.98	18.66	15.09	12.57	11.84
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	0.01	0.46	0.28	0.27	0.23
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	0.81	0.79	0.37	0.13	0.21
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	53.87	34.95	31.27	26.56	17.04
Other Earnings	--	--	--	--	--
BONUS DETAILS
Bonus Equity Share Capital	3.04	3.04	3.04	3.04	3.04
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	--
Non-Current Investments Unquoted Book Value	0.06	0.09	0.09	0.04	2.30
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--